Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Idiopathic Pulmonary Fibrosis
In brief
This is a Phase 3 trial to evaluate the efficacy and safety of 30 milligrams (mg)/kilogram (kg) intravenous (IV) infusions of pamrevlumab administered every 3 weeks as compared to placebo in participants with Idiopathic Pulmonary Fibrosis (IPF). There is a 48-week randomized treatment phase followed by an optional, open-label extension phase.
Key facts
- Study ID
- NCT04419558
- Run by
- Kyntra Bio
- People needed
- 372
- Starts
- 2020-09-30
- Expected to finish
- 2023-09-04
- Last updated by the study team
- 2024-08-12
Who can join
Age: 40 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UC San Francisco — San Francisco, California, United States
- National Jewish Health — Denver, Colorado, United States
- Yale University — New Haven, Connecticut, United States
- St. Francis Medical Center — Clearwater, Florida, United States
- Pulmonary Disease Specialists d/b/a PDS Research — Kissimmee, Florida, United States
- TGH/USF Center for Advanced Lung Disease and Lung Transplant — Tampa, Florida, United States
- Emory University/The Emory Clinic — Atlanta, Georgia, United States
- University of Iowa — Iowa City, Iowa, United States
- The University of Kansas Medical Center — Kansas City, Kansas, United States
- University of Maryland Medical Center — Baltimore, Maryland, United States
- The General Hospital Corporation d/b/a Massachusetts General Hospital — Boston, Massachusetts, United States
- Spectrum Health — Grand Rapids, Michigan, United States
- University of Minnesota — Minneapolis, Minnesota, United States
- Mayo Clinic — Rochester, Minnesota, United States
- Duke University Medical Center — Durham, North Carolina, United States
- PulmonIx, LLC — Greensboro, North Carolina, United States
- Ohio State University — Columbus, Ohio, United States
- Penn State Milton S Hershey Medical Center — Hershey, Pennsylvania, United States
- University of Pennsylvania — Philadelphia, Pennsylvania, United States
- Low Country Lung and Critical Care, PA — Charleston, South Carolina, United States
- The University of Vermont — Burlington, Vermont, United States
- University of Wisconsin Clinical Research — Madison, Wisconsin, United States
- Fundacion Respirar - Centro Médico Dra. De Salvo — Ciudad Autonoma de Buenos Aires (caba), Argentina
- Hospital das Clínicas da UFMG - Centro de Pesquisas Clínicas do Hospital das Clínicas da Universidade Federal de Minas Gerais - CPC HC/UFMG — Belo Horizonte, Minas Gerais, Brazil
- UAB Lung Health Center — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.